Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer
Key Points
Key Points
Diagnosis
...iagnosi...
...y Diagnosed ER-positive, HER2-negative Breast...
Oncotype DX (21-gene recur...
...1.1If a patient has node-negative breast cancer...
...n 1.2In the group of patients in Recom...
...1.3In the group of patients in Rec...
...1.4If a patient is postmenopausal and has...
...ecommendation 1.5In the group of patien...
....6If a patient is premenopausal and has nod...
...on 1.7If a patient has node-positive brea...
...int (70-gene signatu...
...ndation 1.8If a patient is older than 50 and ha...
...ecommendation 1.9If a patient is 50 years of a...
....10If a patient has low clinical risk, regar...
...ion 1.11If a patient has node-positive b...
...ct (12-gene risk score)...
Recommendation 1.12If a patient is postmenopausa...
...mendation 1.13If a patient is premenopausal and...
...mendation 1.14If a patient has brea...
...gna (PAM50)...
...on 1.15If a patient is postmenopau...
...tion 1.16If a patient is premenopa...
...ion 1.17If a patient is postmenopaus...
...mendation 1.18If a patient has node-positiv...
Mammostrat
...insufficient evidence to recommend use of Ma...
Breast Cancer Index...
...patient has ER-positive, HER2-negative...
...patient has ER-positive, HER2-negative, no...
...i67
...commendation 1.19If a patient is postmeno...
...tion 1.20If a patient is postmenopausal and...
...ecommendation 1.21Despite the limitations...
...ohistochemistry 4 (IH...
....22If a patient has node-negative or...
uPA and PAI-...
...nt has ER-positive, HER2-negative (node...
...patient has HER2-positive breast cancer or...
...ended Endocrine Therapy For ER Recepto...
...otype DX, EndoPredict, Prosigna, Ki6...
...commendation 1.23If a patient has node-negative...
BC...
...1.24If a patient has node-negative or...
...tion 1.25If a patient has node-positive brea...
...ment Score post-5 Years (CTS5)...
...dation 1.26If a patient is postmenopau...
...itive Breast Cancer or TNBC...
...DX, EndoPredict, MammaPrint, BCI, Prosigna...
...ndation 1.27If a patient has HER2-po...
...rging Biomarkers
...or-Infiltrating Lymphocytes...
...1.28If a patient has node-negative...
...-L1 TestingĀ...
...ndation 1.29If a patient has node-n...
...rculating Tumor Cells (CTC...
...n 1.30If a patient has node-negative...
Circulating Tumor DNA...
...ation 1.31If a patient has node-negative or node-p...
...le 1. Breast Cancer Biomarkers to...
...e 1. Algorithm on Biomarkers to Guide D...
...Classification of Patients According to C...
...ASCO believes that cancer clinical trials...